Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Metabolic Incentives to Cooperate Controlled by Bacterial Quorum Sensing

By BiotechDaily International staff writers
Posted on 24 Oct 2012
Print article
Scientists have found that bacterial quorum sensing controls when and which cells in a given population will release “public goods” into their environment, and does so in a way that is at least partly achieved by specific metabolic advantage “incentives” for the individual cells.

Quorum sensing (the form of intercellular bacterial communication that enables individual cells to recognize and react to the cell population density of their surrounding community) is a key regulator of the production and release of “public goods” - extracellular products that can be used by any community member. The quorum sensing system is also involved in controlling expression of a few “private goods” - intracellular products not available to other cells. In this study published in the October 12, 2012, issue of the journal Science, the opportunistic lung pathogen Pseudomonas aeruginosa was studied under various metabolic conditions that changed the metabolic cost/benefit balance of producing “public goods” and thereby the competitive balance between “cooperator” cells and “cheater” cells; “cheater” cells being quorum sensing mutants that no longer produce “public goods” in response to increasing population density.

The scientists, from the University of Washington School of Medicine (Seattle, WA), found that quorum sensing–controlled expression of certain intracellular “private goods” can put a metabolic constraint on “cheater” cells and prevent a population collapse. When the researchers manipulated the environment so that the cost of cell cooperation was high and so induced destabilization of cooperation, the “cheater” cells were found to overtake the cooperating producer cells until the population collapsed. The scientists were also able to manipulate environmental conditions to restrict the “cheater” population growth and stabilize quorum sensing (population density) dependent cooperation, thereby providing the “public goods” required to maintain the population and prevent collapse of the community.

Metabolic constraint of social “cheating” provides an explanation for “private goods” regulation by a cooperative system and has general implications for population biology, infection control, and stabilization of quorum-sensing circuits in synthetic biology. The findings also provide additional indication of the potential for developing antibiotic-independent approaches to manage infections. In the future, conditions may be manipulated in order to cause cell populations of dangerous pathogens to collapse - "Perhaps, one day, we'll be able to manipulate infections so that bacterial cooperation is destabilized and infections are resolved," said Dr. Peter Greenberg, UW professor of microbiology and principal author of the study. "We've also gained new insights into how cell cooperation can be stably maintained in biology. It is much more straightforward to study sociality in bacteria than in animals. The payoffs may be in understanding what drives cooperation and conflict in general, and in developing strategies for infection control,” added Prof. Greenberg.

Related Links:

University of Washington School of Medicine



Print article

Channels

Genomics/Proteomics

view channel
Image: A dark field photomicrograph showing the spirochete bacterium Borrelia burgdorferi, the pathogen responsible for causing Lyme disease (Photo courtesy of the CDC).

Statins May Help Block Transmission of Lyme Disease

A recent study found that treatment with cholesterol-lowering statins reduced the number of Borrelia burgdorferi bacteria in rodents, which helped to block transmission of Lyme disease. Lyme disease... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.